解读前景:关于痴呆症和阿尔茨海默病临床决策支持工具的欧洲调查
Ini Umoh1, Xin Xia1, Bengt Winblad2,3
1Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
Dementia and geriatric cognitive disorders
|February 25, 2025
概括
临床医生希望为阿尔茨海默病 (AD) 管理提供用户友好的临床决策支持系统 (CDSS). 关键特征包括准确的AD诊断,治疗资格评估和预后预测,以提高临床效率.
科学领域:
- 神经科学是一个神经科学.
- 医疗信息学 医疗信息学
- 老年病的医生 老年病的医生
背景情况:
- 技术进步为像阿尔茨海默病 (AD) 这样的神经认知疾病提供了改进的临床管理.
- 用户的意见对于开发用于日常临床实践的有效技术至关重要.
- 这项研究的重点是了解临床医生对痴呆症和AD管理临床决策支持系统 (CDSS) 的看法.
研究的目的:
- 确定欧洲临床医生对临床决策支持系统 (CDSS) 的看法.
- 确定痴呆症和AD护理中CDSS所需的功能和实施因素.
主要方法:
- 一项包含65项数字调查被分发给欧洲各地的痴呆专业临床医生.
- 该调查询问了使用CDSS的诊断,疾病修饰疗法和预后的意见.
- 还评估了影响这些工具的实施和使用的因素.
主要成果:
- 84名临床医生做出了反应;超过50%的临床医生缺乏之前的CDSS经验.
- 预测AD可能性是最有价值的诊断功能,而粉样蛋白阳性预测得到了适度的兴趣.
- 评估疾病修饰疗法的治疗资格和预测认知/功能衰退被认为是重要的预后功能.
- 数据准确性和易用性被确定为CDSS采用的关键因素.
结论:
- 未来对AD管理的CDSS开发应该优先考虑精度和用户友好性.
- 这些系统在新的疾病修饰疗法出现时尤为重要.
- 增强的CDSS可以显著提高痴呆症护理的临床决策和效率.
相关概念视频
01:30Dementia
88
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
88
01:22Alzheimer's Disease: Treatment
147
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
147
01:26Alzheimer's Disease: Overview
422
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
422